查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356826

产前检测与新生儿筛检市场报告：2030 年趋势、预测与竞争分析

Prenatal Testing & Newborn Screening Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

产前检测和新生儿筛检趋势和预测

至2030年，全球产前检测和新生儿筛检市场预计将达到108亿美元，2024年至2030年的年复合成长率为12.8%。该市场的主要促进因素是遗传疾病患病的增加和婴儿染色体症候群病例的增加。全球产前检测和新生儿筛检市场的未来看起来充满希望，医院和诊断中心市场也充满机会。

产前检测与新生儿筛检市场洞察

Lucintel 预测，非侵入性检测预计将在预测期内出现高速成长，因为它们不会对胎儿构成风险，而且流产的可能性较低。

随着越来越多的患者选择该设施来做出资讯的决定，预计该医院将在预测期内实现高速成长。

由于该地区遗传性疾病病例数量不断增加以及有利的报销政策，预计北美地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球产前检测与新生儿筛检市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球产前检测和新生儿筛检市场趋势（2018-2023）和预测（2024-2030）
  • 按诊断类型分類的全球产前检测和新生儿筛检市场
    • 侵入性的
    • 非侵入性
  • 按技术分類的全球产前检测和新生儿筛检市场
    • 筛选技术
    • 诊断技术
  • 按最终用途的全球产前检测和新生儿筛检市场
    • 医院
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球产前检测和新生儿筛检市场（按地区）
  • 北美产前检测与新生儿筛检市场
  • 欧洲产前检测与新生儿筛检市场
  • 亚太产前检测与新生儿筛检市场
  • 其他地区产前检测及新生儿筛检市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按诊断类型分類的全球产前检测和新生儿筛检市场成长机会
    • 全球产前检测和新生儿筛检市场的技术成长机会
    • 全球产前检测和新生儿筛检市场成长机会（按最终用途）
    • 全球产前检测和新生儿筛检市场按地区成长机会
  • 全球产前检测和新生儿筛检市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球产前检测和新生儿筛检市场的能力
    • 全球产前检测和新生儿筛检市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • PerkinElmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific
简介目录

Prenatal Testing & Newborn Screening Trends and Forecast

The future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

A more than 150-page report is developed to help in your business decisions.

Prenatal Testing & Newborn Screening by Segment

The study includes a forecast for the global prenatal testing & newborn screening by diagnostic type, technology, end use, and region.

Prenatal Testing & Newborn Screening Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

  • Invasive
  • Non-Invasive

Prenatal Testing & Newborn Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Screening Technology
  • Diagnostic Technology

Prenatal Testing & Newborn Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Others

Prenatal Testing & Newborn Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Prenatal Testing & Newborn Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prenatal testing & newborn screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prenatal testing & newborn screening companies profiled in this report include-

  • Perkinelmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific

Prenatal Testing & Newborn Screening Market Insights

Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Hospital is expected to witness higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.

North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Features of the Global Prenatal Testing & Newborn Screening Market

Market Size Estimates: Prenatal testing & newborn screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prenatal testing & newborn screening market size by diagnostic type, technology, end use, and region. in terms of value ($B).

Regional Analysis: Prenatal testing & newborn screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic types, technologies, end uses, and region.s for the prenatal testing & newborn screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prenatal testing & newborn screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the prenatal testing & newborn screening market size?

Answer: The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030.

Q.2. What is the growth forecast for prenatal testing & newborn screening market?

Answer: The global prenatal testing & newborn screening market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the prenatal testing & newborn screening market?

Answer: The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

Q.4. What are the major segments for prenatal testing & newborn screening market?

Answer: The future of the prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets.

Q.5. Who are the key prenatal testing & newborn screening market companies?

Answer: Some of the key prenatal testing & newborn screening companies are as follows:

  • PerkinElmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific

Q.6. Which prenatal testing & newborn screening market segment will be the largest in future?

Answer: Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Q.7. In prenatal testing & newborn screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the prenatal testing & newborn screening market by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Prenatal Testing & Newborn Screening Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Prenatal Testing & Newborn Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
    • 3.3.1: Invasive
    • 3.3.2: Non-Invasive
  • 3.4: Global Prenatal Testing & Newborn Screening Market by Technology
    • 3.4.1: Screening Technology
    • 3.4.2: Diagnostic Technology
  • 3.5: Global Prenatal Testing & Newborn Screening Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Prenatal Testing & Newborn Screening Market by Region
  • 4.2: North American Prenatal Testing & Newborn Screening Market
    • 4.2.2: North American Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.3: European Prenatal Testing & Newborn Screening Market
    • 4.3.1: European Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.3.2: European Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.4: APAC Prenatal Testing & Newborn Screening Market
    • 4.4.1: APAC Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.4.2: APAC Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.5: ROW Prenatal Testing & Newborn Screening Market
    • 4.5.1: ROW Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.5.2: ROW Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
    • 6.1.2: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Technology
    • 6.1.3: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by End Use
    • 6.1.4: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Region
  • 6.2: Emerging Trends in the Global Prenatal Testing & Newborn Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Prenatal Testing & Newborn Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prenatal Testing & Newborn Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PerkinElmer
  • 7.2: Natera
  • 7.3: Invitae
  • 7.4: Centogene
  • 7.5: Cradle Genomics
  • 7.6: Hoffmann-La Roche
  • 7.7: Quest Diagnostics
  • 7.8: Baebies
  • 7.9: Ravgen
  • 7.10: Eurofins Scientific